https://orcid.org/0000-0002-5160-6374
References
- Mollet TW, Garcia CA, Koester G. Skin metastases from lung cancer. Dermatol Online J. 2009;15(5):1.
- Babacan NA, Kiliçkap S, Sene S, et al. A case of multifocal skin metastases from lung cancer presenting with vasculitic-type cutaneous nodule. Indian J Dermatol. 2015;60(2):213. doi:10.4103/0019-5154.152582
- Dhambri S, Zendah I, Ayadi-Kaddour A, Adouni O, El Mezni F. Cutaneous metastasis of lung carcinoma: a retrospective study of 12 cases. J Eur Acad Dermatol Venereol. 2011;25(6):722–726. doi:10.1111/j.1468-3083.2010.03818.x
- Liao H, Wu S, Karbowitz SR, Morgenstern N, Rose DR. Cutaneous metastasis as an initial presentation of lung adenocarcinoma with KRAS mutation: a case report and literature review. Stem Cell Investig. 2014;1:6. doi:10.3978/j.issn.2306-9759.2014.03.04
- McSweeney WT, Tan K. Cutaneous metastases as a presenting sign of metastatic NSCLC. J Surg Case Rep. 2019;2019(10):rjz279. doi:10.1093/jscr/rjz279
- McGrath RB, Flood SP, Casey R. Cutaneous metastases in non-small cell lung cancer. BMJ Case Rep. 2014;2014:bcr2014205752. doi:10.1136/bcr-2014-205752
- Kummar S, Fogarasi M, Canova A, Mota A, Ciesielski T. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J Cancer. 2002;86(12):1884–1887. doi:10.1038/sj.bjc.6600326
- Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011;19(4):313–317. doi:10.1097/PAI.0b013e318205b059
- Alcaraz I, Cerroni L, Rütten A, Kutzner H, Requena L. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012;34(4):347–393. doi:10.1097/DAD.0b013e31823069cf
- Richardson AM, Havel LS, Koyen AE, et al. Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell-cancer-associated fibroblast interactions during collective invasion. Clin Cancer Res. 2018;24(2):420–432. doi:10.1158/1078-0432.CCR-17-1776
- Jang HR, Shin SB, Kim CH, et al. PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma. Cell Death Differ. 2021;28(9):2745–2764. doi:10.1038/s41418-021-00781-4
- Ambrogi V, Nofroni I, Tonini G, Mineo TC. Skin metastases in lung cancer: analysis of a 10-year experience. Oncol Rep. 2001;8(1):57–61.